Otezla 30 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F1FYN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,685
Award facts
- Contract value 100% obligated
- $11,684.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,684.56 to AmerisourceBergen Drug Corp for the supply of Otezla (apremilast) 30 mg tablets in a quantity of 60 units. This non-competitive, firm fixed-price delivery order was awarded on December 10, 2025, with an ultimate completion date of December 11, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.99 billion pharmaceutical prime vendor agreement running through December 2026 that authorizes the company to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and established federal vendor that serves critical medical procurement needs for military and veteran healthcare systems through the DLA's Medical Supply Chain. The company's existing IDC vehicle enables flexible fulfillment of diverse pharmaceutical requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies. This delivery order for Otezla, a medication used to treat inflammatory conditions, exemplifies the routine pharmaceutical procurement conducted under the prime vendor agreement, which is structured to efficiently meet the Defense Health Agency and other government healthcare system requirements.
Quick answers
Who was awarded contract SPE2DR26F1FYN?
SPE2DR26F1FYN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26F1FYN worth?
The government has obligated $11,685 on SPE2DR26F1FYN.
Is contract SPE2DR26F1FYN an order under another contract?
Yes. SPE2DR26F1FYN is a delivery order under SPE2DR25D2106, an indefinite delivery contract.
Was contract SPE2DR26F1FYN competed?
The extent of competition for SPE2DR26F1FYN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award